Skip to content

Sitting · Plenary

Tuesday 20 January 2026

Date
Tuesday 20 January 2026
Part-session
19–22 January 2026 Mon 19Tue 20Wed 21Thu 22
Decisions
11 decisions: 7 passed, 1 did not pass, 3 without a final vote
Votes
181 votes · 67 roll calls
More facts (5)
Voting time
12:43–13:22
Amendments
50
Previous sitting
Monday 19 January 2026
More

Decisions, 11

Export

Numbered as on the sitting’s record, by kind of decision.

Effect: what the decision did. Final vote: for–against–abstained and how it was recorded. Votes: votes taken on the decision (amendments, split parts, the final vote).
No.DecisionKindEffectFinal voteVotes
No.1 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest Committee report by Tomislav SokolKindNew laws · 1st readingPassed503 for, 57 against, 108 abstained roll callVotes43
No.2 Amending Regulation (EU) 2024/792 establishing the Ukraine Facility KindNew laws · 1st readingUrgent procedure agreedAdopted show of hands — no countVotes1
No.3 Regulation implementing enhanced cooperation on the establishment of the Ukraine Support Loan for 2026 and 2027 KindNew laws · 1st readingUrgent procedure agreedAdopted show of hands — no countVotes1
No.4 Enhanced cooperation on the establishment of a loan for Ukraine KindConsent · Consent procedureUrgent procedure agreedAdopted show of hands — no countVotes1
No.5Objection under Rule 114(3) · delegated act Delegated Regulation supplementing the review of prudential rules for the insurance and reinsurance sector (Solvency II) Motion for a resolutionKindObjectionsObjection failed129 for, 406 against, 129 abstained counted, no namesVotes1
No.6 The 28th Regime: a new legal framework for innovative companies Committee report by René RepasiKindResolutionsAdopted492 for, 144 against, 28 abstained roll callVotes36
No.7 Just transition directive in the world of work: ensuring the creation of jobs and revitalising local economies Committee report by Jana ToomKindResolutionsAdopted420 for, 207 against, 20 abstained roll callVotes53
No.8 Safeguarding and promoting financial stability amid economic uncertainties Committee report by Johan Van OvertveldtKindResolutionsAdopted491 for, 83 against, 84 abstained roll callVotes1
No.9 Humanitarian aid in a time of polycrisis – reaffirming our principles for a more effective and ambitious response to humanitarian crises Committee report by Leire PajínKindResolutionsAdopted444 for, 153 against, 55 abstained roll callVotes4
No.10 Reform of the European Electoral Act – hurdles to ratification and implementation in the Member States Committee report by Borja Giménez LarrazKindResolutionsAdopted417 for, 234 against, 9 abstained roll callVotes21
No.11 Murder of Mehdi Kessaci – urgent need for ambitious European action against drug trafficking Motion for a resolutionKindResolutionsAdoptedAdopted show of hands — no countVotes19

All votes, 67

Export

Every vote of the day recorded by name. A decision can have many votes.

Result: for–against–abstained. For: share of the votes cast. Requested by: the groups that asked for a roll call.
DateVoteKindResultForRequested by
20 Jan 2026Amendment 3, adding text after paragraph 1 The 28th Regime: a new legal framework for innovative companiesAmendment116 for, 489 against, 56 abstained Rejected For 18 %Requested by The Left
20 Jan 2026Final vote Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interestFinal503 for, 57 against, 108 abstained Adopted For 75 %
20 Jan 2026Amendment 247, adding text after recital 22 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interestAmendment224 for, 424 against, 20 abstained Rejected For 34 %Requested by The Left
20 Jan 2026Amendment 256, adding text after recital 12 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interestAmendment362 for, 259 against, 34 abstained Adopted For 55 %Requested by Renew
20 Jan 2026Amendment 259 to recital 4 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interestAmendment197 for, 454 against, 7 abstained Rejected For 30 %Requested by Patriots
20 Jan 2026Amendment 244, adding text after recital 3 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interestAmendment227 for, 299 against, 138 abstained Rejected For 34 %Requested by The Left
20 Jan 2026Amendment 187 to Article 23 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interestAmendment527 for, 121 against, 15 abstained Adopted For 79 %Requested by Patriots
20 Jan 2026Amendment 178 to Article 22 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interestAmendment529 for, 120 against, 16 abstained Adopted For 80 %Requested by Patriots
20 Jan 2026Amendment 170 to Article 21 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interestAmendment525 for, 123 against, 14 abstained Adopted For 79 %Requested by Patriots
20 Jan 2026Amendment 250 to Article 16, after paragraph 2 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interestAmendment141 for, 516 against, 7 abstained Rejected For 21 %Requested by The Left
Show the other 7 votes of this page
Result: for–against–abstained. For: share of the votes cast. Requested by: the groups that asked for a roll call.
DateVoteKindResultForRequested by
20 Jan 2026Amendment 257 to Article 3, paragraph 1, point 5 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interestAmendment325 for, 284 against, 33 abstained Adopted For 51 %Requested by Renew
20 Jan 2026Amendment 164 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interestAmendment450 for, 205 against, 8 abstained Adopted For 68 %Requested by Patriots
20 Jan 2026Amendment 163 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interestAmendment528 for, 123 against, 10 abstained Adopted For 80 %Requested by Patriots
20 Jan 2026Amendment 162 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interestAmendment494 for, 152 against, 17 abstained Adopted For 75 %Requested by Patriots
20 Jan 2026Amendment 159 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interestAmendment517 for, 127 against, 15 abstained Adopted For 78 %Requested by Patriots
20 Jan 2026Amendment 158 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interestAmendment492 for, 159 against, 14 abstained Adopted For 74 %Requested by Patriots
20 Jan 2026Proposal to reject the text Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interestRejection44 for, 600 against, 13 abstained Rejected For 7 %

Open these votes in the register to filter them further.

Day brief

A short account of the day, written by AI from the decisions and their summaries.

AI: The day in brief Written by AI from the official text — check the source

Parliament adopted positions on new laws and resolutions covering medicines, company law, job transitions, and financial stability, while rejecting an objection to insurance rules.

  • Critical medicines supply: Parliament backed new EU rules to secure supplies of critical medicines, boost EU manufacturing, and improve member state coordination. The Left, Greens, S&D, Renew, and EPP supported it; ESN opposed.
  • Solvency II insurance rules: MEPs rejected an objection to a Commission measure amending insurance and reinsurance prudential rules, so the delegated regulation stands as planned.
  • 28th Regime company law: Parliament asked the Commission to propose a voluntary EU-wide corporate form, the Societas Europaea Unificata, to help small firms scale up. Greens, S&D, Renew, EPP, and ECR backed it; The Left, Patriots, and ESN opposed.
  • Just transition jobs: MEPs called for a directive to support workers and regions during green and digital shifts, promoting social dialogue and quality jobs. The Left, Greens, S&D, Renew, and EPP supported it; ECR, Patriots, and ESN opposed.
  • Financial stability measures: Parliament urged completing the Banking Union and Capital Markets Union to absorb shocks, while calling for stronger supervision and crisis preparedness. Greens, S&D, Renew, EPP, and ECR backed it; The Left and ESN opposed.

Report a problem

Connections

The part-session and what the day’s decisions touch.

Other sittings of the part-session

Sources & citation

Where the facts on this page come from, and how to cite it.

Retrieved
25 September 2026

Cite as

European Parliament (2026). “Sitting of Tuesday 20 January 2026”. Sitting, 20 January 2026. sitting MTG-PL-2026-01-20. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/sittings/2026-01-20?vpage=2 (retrieved 25 September 2026). Official sources: Roll-call votes, sitting of 20 January 2026 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2026-01-20-RCV_EN.html; Results of votes, sitting of 20 January 2026 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2026-01-20-VOT_EN.html. Data: EP Open Data API: decisions of the sitting MTG-PL-2026-01-20, https://data.europarl.europa.eu/api/v2/meetings/MTG-PL-2026-01-20/decisions?format=application%2Fld%2Bjson (CC BY 4.0).
BibTeX
@misc{epw-sitting-2026-01-20,
  author = {{European Parliament}},
  title = {{Sitting of Tuesday 20 January 2026}},
  year = {2026},
  date = {2026-01-20},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/sittings/2026-01-20?vpage=2}},
  url = {https://news.eu-parl.st-solutions.dev/sittings/2026-01-20?vpage=2},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Sitting. sitting MTG-PL-2026-01-20. Official source: https://www.europarl.europa.eu/doceo/document/PV-10-2026-01-20-RCV\_EN.html, https://www.europarl.europa.eu/doceo/document/PV-10-2026-01-20-VOT\_EN.html. Data: EP Open Data API: decisions of the sitting MTG-PL-2026-01-20 (CC BY 4.0)}
}